| 1. |
|
|
| 2. |
- Blease, Charlotte R, et al.
(författare)
-
Sharing clinical notes, and placebo and nocebo effects : Can documentation affect patient health?
- 2022
-
Ingår i: Journal of Health Psychology. - : SAGE Publications. - 1359-1053 .- 1461-7277. ; 27:1, s. 135-146
-
Tidskriftsartikel (refereegranskat)abstract
- This paper connects findings from the field of placebo studies with research into patients' interactions with their clinician's visit notes, housed in their electronic health records. We propose specific hypotheses about how features of clinicians' written notes might trigger mechanisms of placebo and nocebo effects to elicit positive or adverse health effects among patients. Bridging placebo studies with (a) survey data assaying patient and clinician experiences with portals and (b) randomized controlled trials provides preliminary support for our hypotheses. We conclude with actionable proposals for testing our understanding of the health effects of access to visit notes.
|
|
| 3. |
|
|
| 4. |
- Cardeña, Etzel, et al.
(författare)
-
The cultural context of hypnosis
- 2010
-
Ingår i: Handbook of clinical hypnosis (2nd Ed). ; , s. 743-771
-
Bokkapitel (refereegranskat)
|
|
| 5. |
- Faria, Vanda, et al.
(författare)
-
Parental Attitudes About Placebo Use in Children
- 2017
-
Ingår i: The Journal of Pediatrics. - : MOSBY-ELSEVIER. - 0022-3476 .- 1097-6833. ; 181, s. 272-278
-
Tidskriftsartikel (refereegranskat)abstract
- Objective To assess parental attitudes regarding placebo use in pediatric randomized controlled trials and clinical care. Study design Parents with children under age 18 years living in the US completed and submitted an online survey between September and November 2014. Results Among all 1300 participants, 1000 (76.9%; 538 mothers and 462 fathers) met the study inclusion criteria. The majority of surveyed parents considered the use of placebos acceptable in some pediatric care situations (86%) and some pediatric trials (91.5%), whereas only 5.7% of parents found the use of placebos in children always unacceptable. The clinical use of placebo was considered acceptable by a majority of parents for only 7 (mostly psychological) of the 17 conditions presented. Respondents' judgment about acceptability was influenced by the doctors' opinions about the therapeutic benefits of placebo treatment, the conditions for pediatric placebo use, transparency, safety, and purity of placebos. Conclusion Most surveyed parents accepted the idea of using placebos in pediatric trials and within the clinic for some conditions without the practice of deception and with the creation of guidelines for ethical and safe use. This study suggests a need to reconsider pediatric trial design and clinical therapy in the light of generally positive parental support of appropriate placebo use.
|
|
| 6. |
- Faria, Vanda, et al.
(författare)
-
Placebos in pediatrics : A cross-sectional survey investigating physicians' perspectives
- 2023
-
Ingår i: Journal of Psychosomatic Research. - : Elsevier BV. - 0022-3999 .- 1879-1360. ; 172
-
Tidskriftsartikel (refereegranskat)abstract
- Objective: Placebo responses are significantly higher in children than in adults, suggesting a potential underused treatment option in pediatric care. To facilitate the clinical translation of these beneficial effects, we explored physicians' current practice, opinions, knowledge, and likelihood of recommending placebos in the future.Methods: A cross-sectional web-based survey administered by REDCap was conducted at Boston Children's Hospital between October 2021 and March 2022. Physicians (n = 1157) were invited to participate through an email containing a link to a 23-item survey designed to assess physicians' attitudes and perceptions towards the clinical use of placebo in pediatrics.Results: From 207 (18%) returned surveys, 109 (9%) were fully completed. Most respondents (79%) believed that enhancing the therapeutic components that contribute to the placebo response may be a way of improving pediatric care. However, whereas most (62%) found placebo treatments permissible, only one-third reported recommending them. In pediatrics, placebos are typically introduced as a medicine that "might help" (43%). The most common treatments recommended to enhance placebo effects are physical therapy, vitamins, and over-the-counter analgesics. Physicians most frequently recommend placebos for occasional pain, headaches, and anxiety disorders. Finally, the great majority of physicians (87%) stated they would be more likely to recommend pla-cebo treatments if there were safety and ethical guidelines for open-label placebos.Conclusions: Placebo treatments seem permissible to physicians in pediatric care, but the development of safety and ethical guidelines may be necessary before physicians systematically incorporate the benefits of the placebo effect in pediatrics.
|
|
| 7. |
- Kirsch, Irving, et al.
(författare)
-
Definitionen von Hypnose und Hypnotisierbarkeit unde deren Bezug zur Suggestion un Suggestibilitaät. Ein Konsensus Statement
- 2011
-
Ingår i: Festschrift für Vladimir Gheorghiu. ; , s. 11-21
-
Bokkapitel (refereegranskat)abstract
- Abstract in UndeterminedThis article reports a consensus that was reached at an Advanced Workshop in Experimental Hypnosis held as part of the joint annual conference of the British Society of Medical and Dental Hypnosis (BSMDH) and the British Society of Experimental and Clinical Hypnosis(BSECH). The unanimous consensus was that conventional definitions of hypnosis and hypnotizability are logically inconsistent and that at least one of them needed to be changed. Participants were divided between the alternatives of (1) broadening the operational definition of hypnosis so as to include responding to so-called waking suggestion and(2) limiting the term ‘hypnotizability’ to the effects of administering a hypnotic induction.
|
|
| 8. |
- Kirsch, Irving, et al.
(författare)
-
Definitions of Hypnosis and Hypnotizability and their Relation to Suggestion and Suggestibility : A Consensus Statement
- 2011
-
Ingår i: Contemporary Hypnosis & Integrative Therapy. - : Crown House Publishing. - 2049-2146. ; 28, s. 107-115
-
Tidskriftsartikel (refereegranskat)abstract
- This article reports a consensus that was reached at an Advanced Workshop in Experimental Hypnosis held as part of the joint annual conference of the British Society of Medical and Dental Hypnosis (BSMDH) and the British Society of Experimental and Clinical Hypnosis (BSECH). The unanimous consensus was that conventional definitions of hypnosis and hypnotizability are logically inconsistent and that at least one of them needed to be changed. Participants were divided between the alternatives of (1) broadening the operational definition of hypnosis so as to include responding to so-called waking suggestion and (2) limiting the term 'hypnotizability' to the effects of administering a hypnotic induction.
|
|
| 9. |
- Stridh, Alexander, et al.
(författare)
-
Placebo Responses Among Men With Erectile Dysfunction Enrolled in Phosphodiesterase 5 Inhibitor Trials : A Systematic Review and Meta-analysis
- 2020
-
Ingår i: JAMA Network Open. - : American Medical Association (AMA). - 2574-3805. ; 3:3
-
Tidskriftsartikel (refereegranskat)abstract
- Importance Placebo responses in the treatment of erectile dysfunction (ED) are poorly described in the literature to date.Objective To quantify the association of placebo with ED outcomes among men enrolled in placebo-controlled, phosphodiesterase 5 inhibitor (PDE5I) trials.Data Sources For this systematic review and meta-analysis, a database search was conducted to identify double-blind, placebo-controlled studies using PDE5Is for the treatment of ED published from January 1, 1998, to December 31, 2018, within MEDLINE, Embase, Cochrane Library, and Web of Science. Only articles published in the English language were included.Study Selection Double-blind, placebo-controlled randomized clinical trials of PDE5Is for ED were included. Studies were excluded if they did not provide distribution measures for statistical analysis. Study selection review assessments were conducted by 2 independent investigators. A total of 2215 studies were identified from the database search, and after review, 63 studies that included 12 564 men were analyzed.Data Extraction and Synthesis Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed in abstracting data and assessing validity. Data were extracted from published reports by 2 independent reviewers. Quality assessment was performed using the Jadad scale. Data were pooled using a random-effects model.Main Outcomes and Measures The main outcome was improvement in the erectile function domain of the International Index of Erectile Function questionnaire in the placebo arm of the included studies. Effect size was reported as bias-corrected standardized mean difference (Hedges g). The hypothesis was formulated before data extraction.Results A total of 63 studies that included 12 564 men (mean [SD] age, 55 [7] years; age range, 36-68 years) were included. Erectile function was significantly improved among participants in the placebo arm, with a small to moderate effect size (Hedges g [SE], 0.35 [0.03]; P < .001). Placebo effect size was larger among participants with ED associated with posttraumatic stress disorder (Hedges g [SE], 0.78 [0.32]; P = .02) compared with the overall analysis. No significant difference was found between placebo and PDE5Is for ED after prostate surgery or radiotherapy (Hedges g [SE], 0.30 [0.17]; P = .08).Conclusions and Relevance In this study, placebo was associated with improvement of ED, especially among men with ED-related posttraumatic stress disorder. No difference was found between placebo and PDE5I among men treated for ED after prostate surgery.
|
|
